A novel adenovirus 19K/IX protein enhances infection by attenuating proteasomal degradation of tyrosine-ubiquitinated capsid protein IX

ABSTRACT Human adenoviruses (HAdVs) are double-stranded DNA viruses that cause a wide range of diseases, including respiratory, ocular, and gastrointestinal infections. HAdVs rely extensively on alternative splicing to expand their coding capacity and regulate gene expression during infection. Using replication-competent epitope-tagged HAdV-C5 viruses, we investigated the function of a newly identified alternatively spliced viral transcript, 19K/IX, derived from the E1B19K and pIX genes. We show that the 19K/IX protein binds to and stabilizes the minor capsid protein IX (pIX), thereby attenuating its proteasomal degradation and enhancing the production of infectious viral progeny. Mechanistically, we demonstrate that pIX degradation is mediated by non-canonical ubiquitination of the conserved tyrosine residues Y14 and Y49, which confer pIX subnuclear localization and partially mediate its interaction with the PSMC3 subunit of the 26S proteasome. Collectively, our study identifies 19K/IX as a novel regulator of HAdV-C5 infection and suggests that non-canonical tyrosine ubiquitination contributes to the regulation of capsid protein IX stability. IMPORTANCE Human adenoviruses (HAdVs) are clinically important pathogens and widely used as therapeutic tools. Because of their compact genomes, HAdVs use their genetic information very efficiently through alternative pre-mRNA processing. Here, we describe and characterize 19K/IX, a novel fusion protein generated by alternative splicing of two viral genes during infection. We demonstrate that 19K/IX stabilizes capsid protein IX by preventing its degradation, revealing a previously unrecognized strategy by which HAdVs ensure efficient production of new virus particles. These findings deepen our understanding of HAdV-C5 gene regulation and protein homeostasis and highlight the functional importance of non-canonical HAdV transcripts.

Authors

Institutions

Publication Details

Journal
mBio
Published
2026-10-14
DOI
https://doi.org/10.1128/mbio.01683-26
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A novel adenovirus 19K/IX protein enhances infection by attenuating proteasomal degradation of tyrosine-ubiquitinated capsid protein IX

Mårten Larsson, Erik Schubert, Tanel Punga, Vasileios Rafail Evangelopoulos
mBio
Virus-based gene therapy research
article

A novel adenovirus 19K/IX protein enhances infection by attenuating proteasomal degradation of tyrosine-ubiquitinated capsid protein IX

Mårten Larsson, Erik Schubert, Tanel Punga, Vasileios Rafail Evangelopoulos
article en

Abstract

ABSTRACT Human adenoviruses (HAdVs) are double-stranded DNA viruses that cause a wide range of diseases, including respiratory, ocular, and gastrointestinal infections. HAdVs rely extensively on alternative splicing to expand their coding capacity and regulate gene expression during infection. Using replication-competent epitope-tagged HAdV-C5 viruses, we investigated the function of a newly identified alternatively spliced viral transcript, 19K/IX, derived from the E1B19K and pIX genes. We show that the 19K/IX protein binds to and stabilizes the minor capsid protein IX (pIX), thereby attenuating its proteasomal degradation and enhancing the production of infectious viral progeny. Mechanistically, we demonstrate that pIX degradation is mediated by non-canonical ubiquitination of the conserved tyrosine residues Y14 and Y49, which confer pIX subnuclear localization and partially mediate its interaction with the PSMC3 subunit of the 26S proteasome. Collectively, our study identifies 19K/IX as a novel regulator of HAdV-C5 infection and suggests that non-canonical tyrosine ubiquitination contributes to the regulation of capsid protein IX stability. IMPORTANCE Human adenoviruses (HAdVs) are clinically important pathogens and widely used as therapeutic tools. Because of their compact genomes, HAdVs use their genetic information very efficiently through alternative pre-mRNA processing. Here, we describe and characterize 19K/IX, a novel fusion protein generated by alternative splicing of two viral genes during infection. We demonstrate that 19K/IX stabilizes capsid protein IX by preventing its degradation, revealing a previously unrecognized strategy by which HAdVs ensure efficient production of new virus particles. These findings deepen our understanding of HAdV-C5 gene regulation and protein homeostasis and highlight the functional importance of non-canonical HAdV transcripts.

mBio
Uppsala University (SE)
Cancerfonden, Knut och Alice Wallenbergs Stiftelse
Good health and well-being
Openalex Percentile: Top 15%
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.